New York Life Investment Management’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
Other funds holding TECH
VCM
VPM
MC
New York Life Investment Management's TECH Position: Q1 2026 in Review
New York Life Investment Management increased its Bio-Techne (TECH) stake by 17% in Q1 2026, buying an estimated $349K and bringing the position to 40,257 shares worth $2.1M. The position accounts for 0.02% of the portfolio, ranked #533.
New York Life Investment Management first reported a position in TECH in Q2 2022 and has held it in 16 quarters since. The position peaked at $3.14M in Q4 2023. 583 funds tracked by Wall St. Rank hold TECH as of Q1 2026.
- New York Life Investment Management held 40,257 shares of Bio-Techne worth $2.1M as of Q1 2026.
- New York Life Investment Management bought 5,818 Bio-Techne shares in Q1 2026, an estimated $349K.
- Bio-Techne made up 0.02% of New York Life Investment Management's portfolio in Q1 2026, its #533 holding.
- New York Life Investment Management first reported a position in Bio-Techne in Q2 2022 and has held it in 16 quarters since.
- New York Life Investment Management's Bio-Techne position peaked at $3.14M in Q4 2023.
- 583 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.
Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.